Anjali Rajadhyaksha, PhD, Director of the Center for Substance Abuse Research at the Lewis Katz School of Medicine at Temple University and Adjunct Professor of Neuroscience Research in Pediatrics at Weill Cornell Medicine, participated in a Q&A interview with the Philadelphia Citizen about a new preclinical study published in Science Advances conducted by Weill Cornell Medicine and Katz School of Medicine investigators, in collaboration with The Center for Youth Mental Health at New York-Presbyterian. Increasing the levels of chemicals naturally produced in the body called endocannabinoids may thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs’ ability to relieve pain, according to the study. Dr. Rajadhyaksha is co-senior author of the study; the other co-senior author is Dr. Francis Lee, Chair of the Department of Psychiatry at Weill Cornell Medicine and Psychiatrist-in-Chief at New York-Presbyterian/Weill Cornell Medical Center. The first author is Arlene Martinez-Rivera, PhD, who was an instructor in Dr. Rajadhyaksha’s lab at the time of the study and is now an Assistant Professor at the Katz School of Medicine.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH